• Home
  • About Us
  • Technology
  • Pipeline
  • Team
  • Partnerships
  • Media
  • Publications
  • Contact Us
HDT Bio
Christopher Pirie

Christopher Pirie

Dec 3, 2023

Christopher Pirie Co-Founder & COO Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module...

Recent Posts

  • MalarVx licenses HDT Bio’s repRNA/LION™ Technology for Novel Malaria Vaccine
  • Science Direct: Some assembly required: a single-RNA vaccine against enterovirus-D68
  • Fierce Biotech: NIH establishes pandemic preparedness network, plans up to $100M in yearly funding for work on new treatments and vaccines
  • HDT Bio to Help Spearhead RNA Vaccine Development in National Pandemic Preparedness Initiative
  • HDT Bio Publishes Peer-Reviewed Article Describing the Development of an RNA Vaccine to Prevent Infection and Disease Caused by Enterovirus D68

Recent Comments

No comments to show.

Privacy Policy

Terms of Use

©2024 HDT Bio

  • Follow
  • Follow